Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Recommended Workflow Methodology in the Creation of an Interactive Application for Patient's Diagnosed with Pancreatic Cancer.

Knight O, Carter CR, Loranger B, Rea PM.

Adv Exp Med Biol. 2019;1171:85-103. doi: 10.1007/978-3-030-24281-7_8.

PMID:
31823242
2.

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.

Dreyer SB, Jamieson NB, Evers L, Duthie F, Cooke S, Marshall J, Beraldi D, Knight S, Upstill-Goddard R, Dickson EJ, Carter CR, McKay CJ, Biankin AV, Chang DK.

Chin Clin Oncol. 2019 Apr;8(2):16. doi: 10.21037/cco.2019.04.06.

3.

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory.

Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143. [Epub ahead of print]

PMID:
30570546
4.

Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.

Cherukuri A, Salama AD, Carter CR, Landsittel D, Arumugakani G, Clark B, Rothstein DM, Baker RJ.

Kidney Int. 2017 Jan;91(1):183-195. doi: 10.1016/j.kint.2016.08.028. Epub 2016 Oct 28.

PMID:
28029430
5.

Hypermutation In Pancreatic Cancer.

Humphris JL, Patch AM, Nones K, Bailey PJ, Johns AL, McKay S, Chang DK, Miller DK, Pajic M, Kassahn KS, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Stone A, Wilson PJ, Anderson M, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Mead RS, Xu Q, Wu J, Pinese M, Cowley MJ, Jones MD, Nagrial AM, Chin VT, Chantrill LA, Mawson A, Chou A, Scarlett CJ, Pinho AV, Rooman I, Giry-Laterriere M, Samra JS, Kench JG, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, McKay CJ, Carter CR, Dickson EJ, Graham JS, Duthie F, Oien K, Hair J, Morton JP, Sansom OJ, Grützmann R, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Rusev B, Corbo V, Salvia R, Cataldo I, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Hofmann O, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Gill AJ, Pearson JV, Grimmond SM, Waddell N, Biankin AV.

Gastroenterology. 2017 Jan;152(1):68-74.e2. doi: 10.1053/j.gastro.2016.09.060. Epub 2016 Nov 15.

PMID:
27856273
6.

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.

Steele CW, Karim SA, Leach JDG, Bailey P, Upstill-Goddard R, Rishi L, Foth M, Bryson S, McDaid K, Wilson Z, Eberlein C, Candido JB, Clarke M, Nixon C, Connelly J, Jamieson N, Carter CR, Balkwill F, Chang DK, Evans TRJ, Strathdee D, Biankin AV, Nibbs RJB, Barry ST, Sansom OJ, Morton JP.

Cancer Cell. 2016 Jun 13;29(6):832-845. doi: 10.1016/j.ccell.2016.04.014. Epub 2016 Jun 2.

7.

A Glasgow Tipple-transjugular intrahepatic portosystemic shunt insertion prior to Whipple resection.

Jabbar SA, Jamieson NB, Morris AJ, Oien KA, Duthie F, McKay CJ, Carter CR, Dickson EJ.

J Surg Case Rep. 2016 May 13;2016(5). pii: rjw089. doi: 10.1093/jscr/rjw089.

8.

Rome IV. Gallbladder and Sphincter of Oddi Disorders.

Cotton PB, Elta GH, Carter CR, Pasricha PJ, Corazziari ES.

Gastroenterology. 2016 Feb 19. pii: S0016-5085(16)00224-9. doi: 10.1053/j.gastro.2016.02.033. [Epub ahead of print]

PMID:
27144629
9.

Targeting inflammation in pancreatic cancer: Clinical translation.

Steele CW, Kaur Gill NA, Jamieson NB, Carter CR.

World J Gastrointest Oncol. 2016 Apr 15;8(4):380-8. doi: 10.4251/wjgo.v8.i4.380. Review.

10.

Serum amylase and C-reactive protein in risk stratification of pancreas-specific complications after pancreaticoduodenectomy.

Palani Velu LK, McKay CJ, Carter CR, McMillan DC, Jamieson NB, Dickson EJ.

Br J Surg. 2016 Apr;103(5):553-63. doi: 10.1002/bjs.10098. Epub 2016 Feb 22.

PMID:
26898605
11.

Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer.

Verma R, Foster RE, Horgan K, Mounsey K, Nixon H, Smalle N, Hughes TA, Carter CR.

Breast Cancer Res. 2016 Jan 26;18(1):10. doi: 10.1186/s13058-015-0669-x.

12.

Minimally Invasive Necrosectomy Techniques in Severe Acute Pancreatitis: Role of Percutaneous Necrosectomy and Video-Assisted Retroperitoneal Debridement.

Logue JA, Carter CR.

Gastroenterol Res Pract. 2015;2015:693040. doi: 10.1155/2015/693040. Epub 2015 Oct 26. Review.

13.

RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.

Palani Velu LK, Steele CW, Dickson EJ, Carter CR, McKay CJ, Horgan PG, McMillan DC, Jamieson NB.

J Natl Cancer Inst. 2015 Aug 6;107(9). pii: djv204. doi: 10.1093/jnci/djv204. Print 2015 Sep. No abstract available.

14.

Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity.

Fatehi M, Carter CR, Youssef N, Hunter BE, Holt A, Light PE.

Biosci Rep. 2015 Jul 7;35(4). pii: e00238. doi: 10.1042/BSR20150143.

15.

SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients.

McGlynn LM, McCluney S, Jamieson NB, Thomson J, MacDonald AI, Oien K, Dickson EJ, Carter CR, McKay CJ, Shiels PG.

PLoS One. 2015 Jun 29;10(6):e0131344. doi: 10.1371/journal.pone.0131344. eCollection 2015.

16.

Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.

Miller BW, Morton JP, Pinese M, Saturno G, Jamieson NB, McGhee E, Timpson P, Leach J, McGarry L, Shanks E, Bailey P, Chang D, Oien K, Karim S, Au A, Steele C, Carter CR, McKay C, Anderson K, Evans TR, Marais R, Springer C, Biankin A, Erler JT, Sansom OJ.

EMBO Mol Med. 2015 Aug;7(8):1063-76. doi: 10.15252/emmm.201404827.

17.

Comparison of Immediate and Delayed Blood Alcohol Concentration Testing.

Vance CS, Carter CR, Carter RJ, Del Valle MM, Peña JR.

J Anal Toxicol. 2015 Sep;39(7):538-44. doi: 10.1093/jat/bkv061. Epub 2015 May 27.

PMID:
26017380
18.

CXCR2 inhibition suppresses acute and chronic pancreatic inflammation.

Steele CW, Karim SA, Foth M, Rishi L, Leach JD, Porter RJ, Nixon C, Jeffry Evans TR, Carter CR, Nibbs RJ, Sansom OJ, Morton JP.

J Pathol. 2015 Sep;237(1):85-97. doi: 10.1002/path.4555. Epub 2015 Jun 4.

19.

Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel.

Ali A, Brown V, Denley S, Jamieson NB, Morton JP, Nixon C, Graham JS, Sansom OJ, Carter CR, McKay CJ, Duthie FR, Oien KA.

BMC Clin Pathol. 2014 Jul 23;14:35. doi: 10.1186/1472-6890-14-35. eCollection 2014.

20.

Routine Drainage After Pancreaticoduodenectomy: Serum Amylase Can Guide Early, Selective Drain Removal.

Palani Velu LK, Chandrabalan V, McMillan DC, McKay CJ, Carter CR, Jamieson NB, Dickson EJ.

Ann Surg. 2015 Dec;262(6):e107. doi: 10.1097/SLA.0000000000000758. No abstract available.

PMID:
24887980
21.

Intracellular long-chain acyl CoAs activate TRPV1 channels.

Yu Y, Carter CR, Youssef N, Dyck JR, Light PE.

PLoS One. 2014 May 5;9(5):e96597. doi: 10.1371/journal.pone.0096597. eCollection 2014. Erratum in: PLoS One. 2015;10(2):e0118385.

22.

Targeting mTOR dependency in pancreatic cancer.

Morran DC, Wu J, Jamieson NB, Mrowinska A, Kalna G, Karim SA, Au AY, Scarlett CJ, Chang DK, Pajak MZ; Australian Pancreatic Cancer Genome Initiative (APGI), Oien KA, McKay CJ, Carter CR, Gillen G, Champion S, Pimlott SL, Anderson KI, Evans TR, Grimmond SM, Biankin AV, Sansom OJ, Morton JP.

Gut. 2014 Sep;63(9):1481-9. doi: 10.1136/gutjnl-2013-306202. Epub 2014 Apr 9.

23.

Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells.

Cherukuri A, Rothstein DM, Clark B, Carter CR, Davison A, Hernandez-Fuentes M, Hewitt E, Salama AD, Baker RJ.

J Am Soc Nephrol. 2014 Jul;25(7):1575-85. doi: 10.1681/ASN.2013080837. Epub 2014 Mar 7.

24.

Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes.

Li A, Morton JP, Ma Y, Karim SA, Zhou Y, Faller WJ, Woodham EF, Morris HT, Stevenson RP, Juin A, Jamieson NB, MacKay CJ, Carter CR, Leung HY, Yamashiro S, Blyth K, Sansom OJ, Machesky LM.

Gastroenterology. 2014 May;146(5):1386-96.e1-17. doi: 10.1053/j.gastro.2014.01.046. Epub 2014 Jan 23.

25.

Staged multidisciplinary step-up management for necrotizing pancreatitis.

da Costa DW, Boerma D, van Santvoort HC, Horvath KD, Werner J, Carter CR, Bollen TL, Gooszen HG, Besselink MG, Bakker OJ.

Br J Surg. 2014 Jan;101(1):e65-79. doi: 10.1002/bjs.9346. Epub 2013 Nov 22. Review.

26.

Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomy.

Palani Velu LK, Chandrabalan VV, Jabbar S, McMillan DC, McKay CJ, Carter CR, Jamieson NB, Dickson EJ.

HPB (Oxford). 2014 Jul;16(7):610-9. doi: 10.1111/hpb.12184. Epub 2013 Nov 7.

27.

'Step-port' laparoscopic cystgastrostomy for the management of organized solid predominant post-acute fluid collections after severe acute pancreatitis.

Gibson SC, Robertson BF, Dickson EJ, McKay CJ, Carter CR.

HPB (Oxford). 2014 Feb;16(2):170-6. doi: 10.1111/hpb.12099. Epub 2013 Mar 29.

28.

The roles of complement receptor 3 and Fcγ receptors during Leishmania phagosome maturation.

Polando R, Dixit UG, Carter CR, Jones B, Whitcomb JP, Ballhorn W, Harintho M, Jerde CL, Wilson ME, McDowell MA.

J Leukoc Biol. 2013 Jun;93(6):921-32. doi: 10.1189/jlb.0212086. Epub 2013 Mar 29.

29.

Pre-operative cardiopulmonary exercise testing predicts adverse post-operative events and non-progression to adjuvant therapy after major pancreatic surgery.

Chandrabalan VV, McMillan DC, Carter R, Kinsella J, McKay CJ, Carter CR, Dickson EJ.

HPB (Oxford). 2013 Nov;15(11):899-907. doi: 10.1111/hpb.12060. Epub 2013 Feb 20.

30.

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.

Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV.

J Clin Oncol. 2013 Apr 1;31(10):1348-56. doi: 10.1200/JCO.2012.46.8868. Epub 2013 Feb 25.

PMID:
23439753
31.

Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.

Denley SM, Jamieson NB, McCall P, Oien KA, Morton JP, Carter CR, Edwards J, McKay CJ.

J Gastrointest Surg. 2013 May;17(5):887-98. doi: 10.1007/s11605-013-2168-7. Epub 2013 Feb 23.

PMID:
23435739
32.

Exploiting inflammation for therapeutic gain in pancreatic cancer.

Steele CW, Jamieson NB, Evans TR, McKay CJ, Sansom OJ, Morton JP, Carter CR.

Br J Cancer. 2013 Mar 19;108(5):997-1003. doi: 10.1038/bjc.2013.24. Epub 2013 Feb 5. Review.

33.

The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Jamieson NB, Chan NI, Foulis AK, Dickson EJ, McKay CJ, Carter CR.

J Gastrointest Surg. 2013 Mar;17(3):511-21. doi: 10.1007/s11605-012-2131-z. Epub 2013 Jan 8.

PMID:
23297028
34.

CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells.

Carter CR, Aravind G, Smalle NL, Cole JY, Savic S, Wood PM.

J Clin Pathol. 2013 Feb;66(2):146-50. doi: 10.1136/jclinpath-2012-201046. Epub 2012 Nov 21.

PMID:
23172556
35.

Do defective B cells contribute to reduced Treg cells and autoimmunity in patients with Common Variable Immunodeficiency?

Carter CR, Aravind G, Smalle NL, Cole JY, Cherukuri A, Savic S, Wood PM.

Immunol Lett. 2012 Nov-Dec;148(1):39-40. doi: 10.1016/j.imlet.2012.07.005. Epub 2012 Jul 31. No abstract available.

PMID:
22874660
36.

The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma.

Jamieson NB, Mohamed M, Oien KA, Foulis AK, Dickson EJ, Imrie CW, Carter CR, McKay CJ, McMillan DC.

Ann Surg Oncol. 2012 Oct;19(11):3581-90. doi: 10.1245/s10434-012-2370-y. Epub 2012 May 4.

PMID:
22555345
37.

Effect of combined dexamethasone/lenalidomide therapy on NK cell-receptor levels in myeloma patients.

Carter CR, Feyler S, Smalle N, Scott GB, Parrish C, Cullen K, Kallmeyer C, Wood PM, Cook G.

Blood. 2011 Dec 8;118(24):6465-6; author reply 6466-8. doi: 10.1182/blood-2011-08-372680. No abstract available.

PMID:
22161851
38.

MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.

Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR, Sansom OJ, Evans TR, McKay CJ, Oien KA.

Clin Cancer Res. 2012 Jan 15;18(2):534-45. doi: 10.1158/1078-0432.CCR-11-0679. Epub 2011 Nov 23.

39.

Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.

Jamieson NB, Carter CR, McKay CJ, Oien KA.

Clin Cancer Res. 2011 May 15;17(10):3316-31. doi: 10.1158/1078-0432.CCR-10-3284. Epub 2011 Mar 28. Review.

40.

Insights into the structure and pharmacology of GABA(A) receptors.

Carter CR, Kozuska JL, Dunn SM.

Future Med Chem. 2010 May;2(5):859-75. doi: 10.4155/fmc.10.178. Review.

PMID:
21426206
41.

Perioperative reductions in circulating lymphocyte levels predict wound complications after excisional breast cancer surgery.

Hogan BV, Peter MB, Achuthan R, Beaumont AJ, Langlands FE, Shakes S, Wood PM, Shenoy HG, Orsi NM, Horgan K, Carter CR, Hughes TA.

Ann Surg. 2011 Feb;253(2):360-4. doi: 10.1097/SLA.0b013e318207c139.

PMID:
21169805
42.

Infected pancreatic necrosis: minimizing the cut.

Wysocki AP, McKay CJ, Carter CR.

ANZ J Surg. 2010 Jan;80(1-2):58-70. doi: 10.1111/j.1445-2197.2009.05177.x. Review.

PMID:
20575882
43.

Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes.

Arumugakani G, Wood PM, Carter CR.

J Clin Immunol. 2010 Mar;30(2):292-300. doi: 10.1007/s10875-009-9351-3. Epub 2009 Dec 9.

PMID:
19997968
44.

Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice.

Carter CR, Whitcomb JP, Campbell JA, Mukbel RM, McDowell MA.

Infect Immun. 2009 Dec;77(12):5668-75. doi: 10.1128/IAI.00802-08. Epub 2009 Sep 21.

45.

A virtual reality atlas of craniofacial anatomy.

Smith DM, Oliker A, Carter CR, Kirov M, McCarthy JG, Cutting CB.

Plast Reconstr Surg. 2007 Nov;120(6):1641-6.

PMID:
18040199
46.

T helper type 1 cytokines and keratinocyte growth factor play a critical role in pseudoepitheliomatous hyperplasia initiation during cutaneous leishmaniasis.

Akilov OE, Donovan MJ, Stepinac T, Carter CR, Whitcomb JP, Hasan T, McDowell MA.

Arch Dermatol Res. 2007 Sep;299(7):315-25. Epub 2007 Jul 21.

PMID:
17643254
47.

The role of mannose receptor during experimental leishmaniasis.

Akilov OE, Kasuboski RE, Carter CR, McDowell MA.

J Leukoc Biol. 2007 May;81(5):1188-96. Epub 2007 Jan 29.

PMID:
17261547
48.

Morphology and growth of the mandible in Crouzon, Apert, and Pfeiffer syndromes.

Boutros S, Shetye PR, Ghali S, Carter CR, McCarthy JG, Grayson BH.

J Craniofac Surg. 2007 Jan;18(1):146-50.

PMID:
17251854
49.

Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor.

Carter CR, Cao L, Kawai H, Smith PA, Dryden WF, Raftery MA, Dunn SM.

Biochem Pharmacol. 2007 Feb 1;73(3):417-26. Epub 2006 Oct 20.

PMID:
17118342
50.

Cholangiography is no substitute.

Wysocki AP, McKay CJ, Carter CR, Imrie CW.

ANZ J Surg. 2006 Jun;76(6):536. No abstract available.

PMID:
16768785

Supplemental Content

Loading ...
Support Center